Prime Medicine Reports Q2 2026 Financial Results

What Happened

• On August 6, 2026, Prime Medicine, Inc. announced its financial results and business highlights for the quarter ended June 30, 2026 via a press release. The company furnished that press release as Exhibit 99.1 to the Form 8-K (Item 2.02).

Key Details

• Filing date: August 6, 2026 (Form 8-K).
• Quarter covered: quarter ended June 30, 2026 (Q2 2026).
• Exhibit: Press release dated August 6, 2026 is furnished as Exhibit 99.1.
• Report signed by CEO Allan Reine on behalf of the company.

Why It Matters

• This 8-K notifies investors that Prime Medicine has released its quarterly earnings and business updates; investors should review the furnished press release (and any accompanying XBRL data) to see reported earnings, revenue, guidance, or operational milestones.
• The filing itself does not include the numeric financials in the 8-K text—read the attached press release (Exhibit 99.1) for the specific figures and details that could affect investment decisions.